Christopher Rhodes to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Christopher Rhodes has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.084
-
Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 2009 Jan; 121(1):69-88.
Score: 0.059
-
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future. Pharmacol Ther. 2016 08; 164:195-203.
Score: 0.025